Bill115th CongressFiled Sep 6, 2018Health
H.R. 6717
Depression Side Effect Labeling Awareness Act of 2018
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Sep 6, 2018)
Depression Side Effect Labeling Awareness Act of 2018
This bill amends the Federal Food, Drug, and Cosmetic Act to require the label of a drug that has an increased risk of suicide or depression to prominently display such risk.
What just happenedSep 6, 2018
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Rush, Bobby L. [D-IL-1](D-IL)Sponsor
1committees3actions6subjects
- Introduced in HouseSep 6, 2018
- Sep 6, 2018IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Sep 6, 2018IntroReferralIntro-H
Introduced in House
- Sep 6, 2018IntroReferral1000
Introduced in House